PharmaShots Weekly Snapshots (April 22 – April 26, 2024)
This week PharmaShots’ news was all about the updates on Regulatory, Clinical Trials, Pharma, Animal Health & MedTech.
Check out our full report below:
Health Canada Accepts Filling and Priority Review of Acadia’s TROFINETIDE for Rett Syndrome
Read More: Health Canada
US FDA Granted Fast Track Designation to Medicure’s MC-1 for PNPO deficiency
Read More: US FDA
EMA Granted Extended Approval to Astellas’ XTANDI (Enzalutamide) for Recurrent Early Prostate Cancer Treatment
Read More: EMA
CSL Vifor and Travere Therapeutics’ FILSPARI (sparsentan) Received European Commission Approval Against IgA Nephropathy
Read More: CSL
Ascendis Pharma Receives MHRA Approval for YORVIPATH (Palopegteriparatide) Against Chronic Hypoparathyroidism in Great Britain
Read More: Ascendis
Blue Arbor’s RESTORE Neuromuscular Interface System Receives FDA Breakthrough Device Designation & TAP Enrolment
Read More: Blue Arbor
Medivir’s MIV-711 Receives FDA ODD and RPDD for Legg-Calvé-Perthes Disease
Read More: Medivir
US FDA Grants Fast Track Designation to Compass Therapeutics’ CTX-009 with Paclitaxel for Previously Treated Metastatic or Locally Advanced Biliary Tract Tumors.
Read More: US FDA
Aurigene and Vipergen Enter into a Strategic Collaboration to Offer DEL Screening and Integrated Drug Discovery Services
Read More: Aurigene and Vipergen
Ipsen Enters into an Option Agreement with Skyhawk Therapeutics for Two RNA Targeting Small Molecules in Rare Neurological Diseases
Read More: Ipsen
Ochre Bio and Boehringer Ingelheim Enter into a Collaboration to Develop and Commercialize Novel Regenerative Treatments for Advanced Liver Disease
Read More: Ochre Bio and Boehringer
Vertex and Treefrog Therapeutics Sign a Licensing Agreement & Collaborate to Enhance Production of Vertex’s Cell Therapies for Type-I Diabetes
Read More: Vertex and Treefrog
Angle Enters into a Supply Agreement with AstraZeneca to use DDR Assay in Pharmaceutical R&D
Read More: Angle
MFDS Korea Approves Onconic Therapeutics’ JAQBO (Zastaprazan citrate) for Treatment of Gastroesophageal Reflux Disease (GERD) in adults
Read More: MFDS Korea
Regeneron and Mammoth Collaborate for CRISPR Gene Editing Therapies Against Multiple Diseases
Read More: Regeneron
Incyte to Acquire Escient Pharmaceuticals and its MRGPR Antagonist Assets
Read More: Incyte
Labcorp to Acquire Invitae Under US Bankruptcy Code Section 363
Read More: Labcorp
Cochlear's Osia System Gets FDA Clearance for Children Aged 5 Years and Above
Read More: Cochlear's
Immunovia Reports Positive Results of Next Generation Test from Model Development Study for Pancreatic Cancer Detection.
Read More: Immunovia
Hepion Pharmaceuticals Begins Wind-Down Activities in ASCEND-NASH P-IIb Study
Read More: Hepion
GENETIKA+ and NeuroSense Commence Precision Medicine Collaboration with the Ongoing P-II Trial in Alzheimer’s Disease
Read More: GENETIKA+
Krystal Biotech doses First Patient with Inhaled KB707 in the P-I study for treating Locally Advanced or Metastatic Solid Tumors of the Lung
Read More: Krystal Biotech
Sanofi’s Rilzabrutinib Meets Primary Endpoint of the LUNA-3 (P-III) Study for the Treatment of Immune Thrombocytopenia (ITP)
Read More: Sanofi
Neurocrine Biosciences Reports Positive Results from P-II study of NBI-1065845 in MDD
Read More: Neurocrine
CureVac collaborates with GSK to Initiate P-I/II study of Avian Influenza (H5N1)
Read More: CureVac
Atom Bioscience Initiates Enrolment in Global P-IIb/III Study of ABP-671 to Treat Chronic Gout in US
Read More: Atom Bioscience
Vistagen Reports Positive Results from P-IIa Study of PH15 for Improvement of Psychomotor Impairment
Read More: Vistagen
Cresilon Teams Up with Covetrus, MWI Animal Health, and Patterson Veterinary Supply for VETIGEL (Haemostatic Gel)
Read More: Cresilon
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.